Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors. The Diabetes Medication segment includes metformin hydrochloride tablets, enteric-coated tablets, and calcium hydroxybenzenesulfonate capsules. The Biochemical Drugs segment includes medication such as compound bone peptide injections, oxytocin injections, and heparin sodium injections. The company was founded on November 6, 1993 and is headquartered in Fuzhou, China.